These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10680060)

  • 1. What's sex got to do with it?
    Brown AJ
    Curr Opin Lipidol; 1999 Dec; 10(6):641-4. PubMed ID: 10680060
    [No Abstract]   [Full Text] [Related]  

  • 2. Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis.
    Sullivan JL
    Am Heart J; 2003 Feb; 145(2):190-4. PubMed ID: 12595829
    [No Abstract]   [Full Text] [Related]  

  • 3. [Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases].
    Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):321-3. PubMed ID: 12947970
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: observation versus intervention--what's different?
    Barrett-Connor E
    Int J Epidemiol; 2004 Jun; 33(3):457-9. PubMed ID: 15166202
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy: where we stand in Europe.
    Rosano GM; Simon T; Mercuro G; Sans S; Schenck-Gustaffson K; Stevenson JC; Swahn E; Jaillon P
    Eur Heart J; 2001 Mar; 22(6):439-41. PubMed ID: 11237534
    [No Abstract]   [Full Text] [Related]  

  • 6. [What's new in hormone replacement therapy for postmenopausal women? I. Advantages of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):515-21. PubMed ID: 11014096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How we got to the Women's Health Initiative hormone replacement trial.
    Gambone JC
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S1-2. PubMed ID: 12625630
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone replacement therapy and cardiovascular disease: a joint statement.
    Abramson B; Derzko C; Lalonde A; Reid R; Turek M; Wielgosz A; ; ;
    Can J Cardiol; 2002 Jul; 18(7):723-4. PubMed ID: 12167958
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statistical cause and association (I). Critique of the cause].
    Gueyffier F
    Rev Prat; 2003 Apr; 53(8):817-9. PubMed ID: 12793161
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy and clinical trial.
    Ogunko A
    Curr Opin Lipidol; 1999 Dec; 10(6):645-7. PubMed ID: 10680061
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.
    Mosca L; Manson JE; Sutherland SE; Langer RD; Manolio T; Barrett-Connor E
    Circulation; 1997 Oct; 96(7):2468-82. PubMed ID: 9337227
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen.
    Leiter LA
    Can J Cardiol; 2000 Aug; 16 Suppl E():13E-16E. PubMed ID: 10906619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HRT story: lessons for epidemiologists.
    Davey Smith G
    Int J Epidemiol; 2003 Oct; 32(5):897. PubMed ID: 14559774
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy and cardiovascular disease revisited.
    Stevenson JC
    Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
    Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
    Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
    [No Abstract]   [Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and cardiovascular disease: one view of the elephant.
    Speroff L
    Menopause; 2005; 12(4):357-8. PubMed ID: 16037747
    [No Abstract]   [Full Text] [Related]  

  • 18. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
    Walsh BW
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
    Rossouw JE
    Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited.
    Pines A; Sturdee DW; Birkhäuser MH;
    Climacteric; 2007 Jun; 10(3):195-6. PubMed ID: 17487646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.